ADCs: When Bioprocessing Becomes Toxic
January 31, 2025
Doing more to ease the challenges of antibody drug conjugate manufacturing.
3 min read

January 31, 2025
Doing more to ease the challenges of antibody drug conjugate manufacturing.
3 min read
January 31, 2025
And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.
3 min read
January 30, 2025
The Trump administration’s move to pause federal funding while projects are vetted causes concern and lawsuits
3 min read
January 30, 2025
What can we expect the US life sciences sector to look like over the course of the next four years as Donald Trump takes up his presidency?
6 min read
January 29, 2025
Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe
1 min read
January 29, 2025
Why mRNA will be a key disrupter in the coming years; experts from CureVac and Omega Therapeutics give their views.
2 min read
January 28, 2025
How understanding and manipulating senescence dynamics could optimize cancer therapies and improve patient outcomes.
4 min read
January 28, 2025
“We have science officers who manage all our grants and work closely with applicants to guide them through the process. Unlike many funding entities, we’re highly participatory. We want to do everything we can to help applicants succeed.”
6 min read
January 27, 2025
How can you ensure your gene therapy research won’t be slowed down by synthesis problems?
4 min read
January 27, 2025
Who will be the grand winner of our 2024 Innovation Awards?
1 min read
False
False